State Street’s Arcadia Biosciences RKDA Stock Holding History

State Street’s Portfolio RKDA Stock Details RKDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16.8K	Hold	12,146	–	–	﹤0.01%	4228
2025 Q4	$24K	Hold	12,146	–	–	﹤0.01%	4233
2025 Q3	$42.1K	Hold	12,146	–	–	﹤0.01%	4174
2025 Q2	$53.6K	Hold	12,146	–	–	﹤0.01%	4085
2025 Q1	$34.5K	Hold	12,146	–	–	﹤0.01%	4143
2024 Q4	$71.9K	Hold	12,146	–	–	﹤0.01%	4059
2024 Q3	$34K	Hold	12,146	–	–	﹤0.01%	4162
2024 Q2	$38.3K	Hold	12,146	–	–	﹤0.01%	4191
2024 Q1	$26.4K	Hold	12,146	–	–	﹤0.01%	4256
2023 Q4	$36.8K	Hold	12,146	–	–	﹤0.01%	4255
2023 Q3	$40.3K	Hold	12,146	–	–	﹤0.01%	4335
2023 Q2	$47.1K	Hold	12,146	–	–	﹤0.01%	4434
2023 Q1	$90.7K	Buy	12,146 +9,601	+377%	+$102K	﹤0.01%	4346
2022 Q4	$27.6K	Sell	2,545 -3	-0.1%	-$43	﹤0.01%	4680
2022 Q3	$54K	Hold	2,548	–	–	﹤0.01%	4640
2022 Q2	$102K	Buy	2,548 +63	+3%	+$2.9K	﹤0.01%	4529
2022 Q1	$139K	Buy	2,485 +1,079	+77%	+$51.5K	﹤0.01%	4521
2021 Q4	$58K	Hold	1,406	–	–	﹤0.01%	4673
2021 Q3	$116K	Buy	1,406 +498	+55%	+$46.7K	﹤0.01%	4509
2021 Q2	$108K	Buy	+908	New	+$99K	﹤0.01%	4347

Other funds holding RKDA

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

State Street's RKDA Position: Q1 2026 in Review

State Street held its Arcadia Biosciences (RKDA) position steady in Q1 2026 at 12,146 shares worth $16.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4228.

State Street first reported a position in RKDA in Q2 2021 and has held it in 20 quarters since. The position peaked at $139K in Q1 2022. 16 funds tracked by Wall St. Rank hold RKDA as of Q1 2026.

State Street held 12,146 shares of Arcadia Biosciences worth $16.8K as of Q1 2026.
State Street left its Arcadia Biosciences share count unchanged in Q1 2026.
Arcadia Biosciences made up ﹤0.01% of State Street's portfolio in Q1 2026, its #4228 holding.
State Street first reported a position in Arcadia Biosciences in Q2 2021 and has held it in 20 quarters since.
State Street's Arcadia Biosciences position peaked at $139K in Q1 2022.
16 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.